FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2994812022> ?p ?o ?g. }

• W2994812022 endingPage "839" @default.
• W2994812022 startingPage "826" @default.
• W2994812022 abstract "Abstract Background Hyperkalemia rates in renin–angiotensin–aldosterone system (RAAS) inhibitor users, and factors associated with treatment interruptions and cessations, have not been explored in a large, population-wide database. Methods RAAS inhibitor users were identified in the linked UK Clinical Practice Research Datalink-Hospital Episodes Statistics data set, 2009–15. Treatment interruptions (no active prescription followed by reappearance) and cessations were determined. Hyperkalemia (serum K+&gt;5.5 mmol/L) rates were calculated and factors associated with interruptions and cessations modeled using time-varying Cox regression, including hyperkalemia (as a time-dependent variable). Results Among 434 027 RAAS inhibitor users, the hyperkalemia rate was 1.30 (95% confidence interval 1.28–1.32) per 100 patient-years. Of 73.7% of patients who experienced off-treatment periods, 57.6% experienced interruption only, 7.5% cessation only and 8.6% both. Within 1 year of initiating RAAS inhibitor treatment, approximately one-third of the patients experienced interruption or cessation. Hazard ratios for patients with severe hyperkalemia were 1.10 (10.5–1.16) for interruptions and 3.37 (3.25–3.50) for cessation. Compared with no chronic kidney disease (CKD), risk of interruption was 1.20 (1.16–1.25) and 1.57 (1.44–1.72) for Stages 4 and 5, respectively, and of cessation was 2.20 (2.07–2.33) and 2.87 (2.56–3.22). Risk of interruption increased for patients with heart failure or diabetes [1.04 (1.02–1.05); 1.13 (1.12–1.14), respectively] but the risk of cessation decreased [0.85 (0.82–0.87); 0.92 (0.90–0.94)]. Conclusions Risk of RAAS inhibitor interruption and cessation increased as CKD stage progressed. Efforts targeting reasons for interruptions and, especially, cessations, such as hyperkalemia prevention, could decrease off-treatment periods for patients who would otherwise benefit, such as those with CKD, heart failure or diabetes." @default.
• W2994812022 created "2019-12-26" @default.
• W2994812022 creator A5009525675 @default.
• W2994812022 creator A5017256940 @default.
• W2994812022 creator A5046122040 @default.
• W2994812022 creator A5053972026 @default.
• W2994812022 creator A5076073719 @default.
• W2994812022 date "2019-12-17" @default.
• W2994812022 modified "2023-10-14" @default.
• W2994812022 title "Risk of hyperkalemia from renin–angiotensin–aldosterone system inhibitors and factors associated with treatment discontinuities in a real-world population" @default.
• W2994812022 cites W122788210 @default.
• W2994812022 cites W1756552807 @default.
• W2994812022 cites W1970939567 @default.
• W2994812022 cites W1988582819 @default.
• W2994812022 cites W1997455782 @default.
• W2994812022 cites W2015959379 @default.
• W2994812022 cites W2041162893 @default.
• W2994812022 cites W2055864845 @default.
• W2994812022 cites W2099417346 @default.
• W2994812022 cites W2100169278 @default.
• W2994812022 cites W2117371940 @default.
• W2994812022 cites W2118021989 @default.
• W2994812022 cites W2119852447 @default.
• W2994812022 cites W2126125759 @default.
• W2994812022 cites W2129403061 @default.
• W2994812022 cites W2152271789 @default.
• W2994812022 cites W2324948948 @default.
• W2994812022 cites W2530951758 @default.
• W2994812022 cites W2580470294 @default.
• W2994812022 cites W2608320814 @default.
• W2994812022 cites W2654724079 @default.
• W2994812022 cites W2725821506 @default.
• W2994812022 cites W2737005781 @default.
• W2994812022 cites W2753828872 @default.
• W2994812022 cites W2762535810 @default.
• W2994812022 cites W2763344715 @default.
• W2994812022 cites W2764108010 @default.
• W2994812022 cites W2771112370 @default.
• W2994812022 cites W2772387421 @default.
• W2994812022 cites W2777100344 @default.
• W2994812022 cites W2799681939 @default.
• W2994812022 cites W2888038580 @default.
• W2994812022 cites W4238907867 @default.
• W2994812022 doi "https://doi.org/10.1093/ndt/gfz263" @default.
• W2994812022 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31846025" @default.
• W2994812022 hasPublicationYear "2019" @default.
• W2994812022 type Work @default.
• W2994812022 sameAs 2994812022 @default.
• W2994812022 citedByCount "18" @default.
• W2994812022 countsByYear W29948120222020 @default.
• W2994812022 countsByYear W29948120222021 @default.
• W2994812022 countsByYear W29948120222022 @default.
• W2994812022 countsByYear W29948120222023 @default.
• W2994812022 crossrefType "journal-article" @default.
• W2994812022 hasAuthorship W2994812022A5009525675 @default.
• W2994812022 hasAuthorship W2994812022A5017256940 @default.
• W2994812022 hasAuthorship W2994812022A5046122040 @default.
• W2994812022 hasAuthorship W2994812022A5053972026 @default.
• W2994812022 hasAuthorship W2994812022A5076073719 @default.
• W2994812022 hasBestOaLocation W29948120221 @default.
• W2994812022 hasConcept C126322002 @default.
• W2994812022 hasConcept C207103383 @default.
• W2994812022 hasConcept C2778525890 @default.
• W2994812022 hasConcept C2778653478 @default.
• W2994812022 hasConcept C2780243291 @default.
• W2994812022 hasConcept C2908647359 @default.
• W2994812022 hasConcept C44249647 @default.
• W2994812022 hasConcept C50382708 @default.
• W2994812022 hasConcept C71924100 @default.
• W2994812022 hasConcept C99454951 @default.
• W2994812022 hasConceptScore W2994812022C126322002 @default.
• W2994812022 hasConceptScore W2994812022C207103383 @default.
• W2994812022 hasConceptScore W2994812022C2778525890 @default.
• W2994812022 hasConceptScore W2994812022C2778653478 @default.
• W2994812022 hasConceptScore W2994812022C2780243291 @default.
• W2994812022 hasConceptScore W2994812022C2908647359 @default.
• W2994812022 hasConceptScore W2994812022C44249647 @default.
• W2994812022 hasConceptScore W2994812022C50382708 @default.
• W2994812022 hasConceptScore W2994812022C71924100 @default.
• W2994812022 hasConceptScore W2994812022C99454951 @default.
• W2994812022 hasFunder F4320307770 @default.
• W2994812022 hasIssue "5" @default.
• W2994812022 hasLocation W29948120221 @default.
• W2994812022 hasOpenAccess W2994812022 @default.
• W2994812022 hasPrimaryLocation W29948120221 @default.
• W2994812022 hasRelatedWork W1727188710 @default.
• W2994812022 hasRelatedWork W1972357283 @default.
• W2994812022 hasRelatedWork W2055262266 @default.
• W2994812022 hasRelatedWork W2119154902 @default.
• W2994812022 hasRelatedWork W2133235702 @default.
• W2994812022 hasRelatedWork W2203903734 @default.
• W2994812022 hasRelatedWork W2585143408 @default.
• W2994812022 hasRelatedWork W2917746345 @default.
• W2994812022 hasRelatedWork W4200305071 @default.
• W2994812022 hasRelatedWork W4245599485 @default.
• W2994812022 hasVolume "36" @default.
• W2994812022 isParatext "false" @default.
• W2994812022 isRetracted "false" @default.

• next